spi-1620
Showing 1 - 3 of 3
Non Small Cell Lung Cancer (NSCLC) Trial in United States (SPI-1620, Docetaxel)
Terminated
- Non Small Cell Lung Cancer (NSCLC)
- SPI-1620
- Docetaxel
-
Cincinnati, Ohio
- +4 more
Oct 8, 2021
Carcinoma Trial in San Antonio (SPI-1620)
Completed
- Carcinoma
- SPI-1620
-
San Antonio, TexasSTART
Oct 17, 2013